The market for cell therapy in the treatment of Acute Lymphocytic Leukemia is experiencing significant growth. The increasing prevalence of ALL, coupled with the rising adoption of innovative treatment options, has fueled the demand for cell therapy. According to market research reports, the global Acute Lymphocytic Leukemia cell therapy market is projected to witness substantial growth in the coming years.